Elevation Wealth Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Elevation Wealth Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.3K	Buy	+101	New	+$22.1K	0.01%	522

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Elevation Wealth Partners's JAZZ Position: Q2 2026 in Review

Elevation Wealth Partners opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 101 shares worth $24.3K. The stake represents 0.01% of the portfolio and ranks #522 among its holdings.

174 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Elevation Wealth Partners held 101 shares of Jazz Pharmaceuticals worth $24.3K as of Q2 2026.
Jazz Pharmaceuticals was a new Elevation Wealth Partners position in Q2 2026.
Jazz Pharmaceuticals made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #522 holding.
174 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.